___

1. Atagun MI, Balaban OD, Lordoglu DY, Evren EC. Lithium and valproate may affect motor and sensory speed in patients with bipolar disorder. The Bulletin of Clinical Psychopharmacology 2013; 23:305-314. [CrossRef]

2. Atagun MI, Oral ET, Sevinc C. Polycystic kidney disease in a patient using lithium chronically. Turk Psikiyatri Derg 2013; 24:213.

3. Patel M, Harrison S, Sinclair R. Drugs and hair loss. Dermatol Clin 2013; 31:67-73. [CrossRef]

4. Suzuki T, Koizumi J, Moroji T, Shiraishi H, Hori T, Baba A, Kawai N, Tada K.. Effects of long-term anticonvulsant therapy on copper, zinc, and magnesium in hair and serum of epileptics. Biol Psychiatry 1992; 31:571–581. [CrossRef]

5. Stroud JD. Diagnosis and management of the hair loss patient. Cutis 1987; 40:272–276.

6. Wichniak A, Jarkiewicz M, Okruszek Ł, Wierzbicka 3, HolkaPokorska J, Rybakowski JK. Low risk for switch to mania during treatment with sleep promoting antidepressants. Pharmacopsychiatry 2015; 25:83-88. [CrossRef]

7. De Bodinat C, Guardiola-Lemaitre B, Mocaër E, Renard P, Muñoz C, Millan MJ. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov 2010; 9:628-642. [CrossRef]

8. Grover C, Khurana A. Telogen effluvium. Indian J Dermatol Venereol Leprol 2013; 79:591. [CrossRef]

9. Singh M, Jadhav HR. Melatonin: functions and ligands. Drug Discov Today 2014; 19:1410-1418. [CrossRef]

10. Fischer TW, Slominski A, Tobin DJ, Paus R. Melatonin and the hair follicle. J Pineal Res 2008; 44:1-5.